Search results
Mayo Clinic must face religious bias claims over COVID vaccine policy, court rules
Reuters· 2 days agoA U.S. appeals court on Friday revived a lawsuit accusing the Mayo Clinic in Minnesota of illegally...
New COVID-19 'FLiRT' Variants Are The Most Dominant In The U.S.
Women's Health via AOL· 5 days agoThe FDA and CDC will meet on June 5 to make recommendations "on the strain(s) to be included in the...
Cracking the genetic code for COVID-19 vaccine effectiveness
Medical Xpress· 4 days agoHLA genes play a crucial role in the immune system's ability to recognize and respond to foreign...
Early signs of rising COVID in California as new FLiRT subvariants dominate
LA Times via Yahoo News· 1 day agoCalifornia may be headed to an earlier start to the summer COVID-19 season than normal as the latest...
What Are The Symptoms Of The New COVID-19 Variants?
IFLScience· 5 days agoCOVID-19 is very much still with us – and if you’re anything like us, you’ll have noticed more and more people complaining that they’re getting sick over...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 3 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This ...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA Today· 4 days agoWhen COVID-19 vaccines entered the commercial market last fall, the federal government introduced a...
Trump has to disavow his COVID vaccine to keep voters from RFK Jr. and his anti-vax clout
USA TODAY Opinion via Yahoo News· 5 days agoSounds like a great victory to trumpet when you seek another term in office, right? Not if you're...
Arizona researcher publishes study on COVID-19 vaccine and tinnitus
ABC 15 Phoenix· 2 days agoA newly published scientific study about the COVID-19 vaccine found people with certain preexisting medical conditions were more likely ...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 9 hours agoThe past two-and-a-half years have been rough for Moderna (NASDAQ: MRNA). Though the biotech was...